Left ventricular (LV)' systole can be divided into phases: isovolumic contraction, ejection, end-systole, and isovolumic relaxation (1). Indices have been developed that describe LV performance during each of these four phases. However, it has been difficult to provide a description of the LV that spans all four phases, unifying and relating the various measures of LV performance. One possibility is to consider that LV systolic pumping function can be described as a time-varying elastance (2-5). In this concept, the LV is considered to behave as an elastic structure that stiffens in a predictable manner during systole. The LV pressure, P(t), at any time after the onset of contraction, t, is described by: P(t) = E(t) [V(t) -V0], where E(t) is LV elastance at t, V(t) the LV volume at t, and V0 the minimum volume required for the LV to generate super-atmospheric pressure. LV elastance, E(t), reaches a maximum value, E., at time t.,,, which has been termed end-systole. Ema,31which is the slope of the end-systolic pressure (PEs)-volume (VEs) relation, is a measure ofthe global inotropic state of the LV and is relatively insensitive to changes in loading conditions in isolated canine hearts (2, 3, 5-10), conscious dogs (1 1), and man (12, 13). Inotropic stimulation with catecholamines increases Emax and decreases t., the time from enddiastole to end-systole (2-4).
Introduction
Because catecholamines and digitalis have different effects on the time course of myocardial intracellular calcium concentration, their effects on the time course of left ventricular contraction and relaxation may also be different. To study this question, dogs were instrumented to measure left ventricular pressure and determine left ventricular volume from three ultrasonic dimensions. After full recovery from the instrumentation, the effects of dobutamine (2-10 jig/kg), ouabain (0.5 mg i.v.) alone, and ouabain given after propanolol (2 mg/kg i.v.), or phentolamine (5 mg i.v.) and incremental doses of ouabain (0.25-0.75 mg i.v.) were assessed on different days. Left ventricular pressure and volume were varied by caval occlusions. Dobutamine significantly increased the slope of the left ventricular end-systolic pressure-volume relation (E..) and the slope of the dP/dt. -end-diastolic volume relation (dE/dt.j), while significantly decreasing the time from end-diastole to end-systole (t...) and the time constant (T) of the isovolumic fall in left ventricular pressure. Ouabain also increased E.., and dE/dt,... but did not alter t. or T. Dobutamine produced a greater increase in dE/dt, than in E., whereas ouabain produced similar increases in both. These effects of ouabain were not altered by pretreatment with propanolol or phentolamine.
We conclude that although dobutamine and ouabain are both positive inotropes that increase E,.rn, dobutamine speeds the rate of left ventricular contraction (t.u) and relaxation (T), whereas ouabain does not. These effects of ouabain and dobutamine on global parameters of left ventricular chamber performance mirror their influence on intracellular calcium availability. Furthermore, these observations are consistent with the predictions of the time-varying elastance model of the left ventricle and support its usefulness as a conceptual framework to understand and link events occurring during isovolumic contraction, end-systole, and isovolumic relaxation.
Left ventricular (LV)' systole can be divided into phases: isovolumic contraction, ejection, end-systole, and isovolumic relaxation (1) . Indices have been developed that describe LV performance during each of these four phases. However, it has been difficult to provide a description of the LV that spans all four phases, unifying and relating the various measures of LV performance. One possibility is to consider that LV systolic pumping function can be described as a time-varying elastance (2) (3) (4) (5) . In this concept, the LV is considered to behave as an elastic structure that stiffens in a predictable manner during systole. The LV pressure, P(t), at any time after the onset of contraction, t, is described by:
, where E(t) is LV elastance at t, V(t) the LV volume at t, and V0 the minimum volume required for the LV to generate super-atmospheric pressure. LV elastance, E(t), reaches a maximum value, E., at time t.,,, which has been termed end-systole. Ema,31which is the slope of the end-systolic pressure (PEs)-volume (VEs) relation, is a measure ofthe global inotropic state of the LV and is relatively insensitive to changes in loading conditions in isolated canine hearts (2, 3, 5-10), conscious dogs (1 1), and man (12, 13) . Inotropic stimulation with catecholamines increases Emax and decreases t., the time from enddiastole to end-systole (2-4).
In addition to the PES VEs relation, the time-varying elastance model has other implications that suggest links between the four phases ofsystole. For example, the model suggests that the maximum rate of rise of LV pressure (dP/dt4,), normally occurring during isovolumic contraction, is linearly related to the LV end-diastolic volume (VED) (3, 4) . The slope of this relation, dE/dtm., is also predicted to be sensitive to inotropic state and proportional to Ema/tm., providing a link between events occurring during isovolumic contraction and at endsystole. Further consideration of the time-varying elastance hypothesis (Appendix) also suggests that the rate of LV pressure fall during isovolumic relaxation should be inversely proportional to tm.. These predictions of the time-varying elastance model linking events occurring during isovolumic contraction (dP/dtm.,-VED relation), at end-systole (the PES-VES relation and tma), and during isovolumic relaxation (T) suggest that this model may provide a unified description of LV performance throughout systole.
The increase in LV elastance after electrical stimulation is a manifestation of the tension generated by the sarcomeres reflected through the complex geometry of the LV chamber ( 14, 15) . Because the force of sarcomere contraction is directly related to amount of calcium available to the contractile proteins, the time course of LV systolic elastance should follow the time course of calcium availability, though lagging behind in time. Studies using the bioluminescent indicator aequorin suggest that catecholamines increase the peak amount of calcium available after electrical stimulation and also decrease the time required to achieve this peak (13, 16 
Methods
Instrumentation. 16 healthy, adult mongrel dogs weighing 23±3 kg (mean±SD) were instrumented by a slight modification ofa previously described technique (4, 17, 18) . A sterile left lateral thoracotomy was performed under anesthesia with halothane (1-2%) after induction with xylene (1 mg/kg) and sodium thiopental (6 mg/kg). The pericardium was opened widely. A micromanometer pressure transducer (Konigsberg Instruments, Inc., Pasadena, CA) and a polyvinyl catheter for transducer calibration (inside diameter, 1.1 mm) were inserted through the LV apex. Three pairs of ultrasonic crystals (5 MHz) were implanted in the endocardium of the LV to measure the anterior-posterior, septal-lateral, and base-apex (long-axis) dimensions. Bipolar pacing leads were sutured to the left atrial appendage. Hydraulic occluder cuffs were placed around the inferior and superior venae cavae.
Data collection. All studies were performed after full recovery from the thoracotomy (10-14 d) with the dogs lying on their right sides in a sling. The LV catheter was connected to a pressure transducer (Statham P23DB) calibrated with a mercury manometer. The signal from the micromanometer was adjusted to match that of the catheter. The transit time of 5 MHz sound between the crystal pairs was determined and converted to distance assuming a constant velocity of sound in blood of 1.55 m/ms. The first derivative of LV pressure (dP/dt) was obtained by electronically differentiating the micromanometer signal using an analogue circuit with a linear frequency response to > 70 Hz. The analog signals were recorded on an eightchannel oscilligraph (Beckman Instruments Inc., Fullerton, CA), digitized with an on-line analog-to-digital converter (Data Translation Devices, Marlboro, MA) at 200 Hz, and stored on a floppy disk memory system utilizing a computer system (PDP 11/23, Digital Equipment Corp., Marlboro, MA).
Experimental protocol. To avoid the confounding influences of respiratory changes in intrathoracic pressure and variations in the level of autonomic tone, the dogs were sedated with fentanyl (0.03-0.06 mg/kg i.v.) in combination with droperidol (1.5-3.0 mg/kg i.v.), given 0.5 h after pretreatment with xylene (1 mg/kg i.m.), and intubated. All data were recorded during 12-s periods while the dogs were apneic, with the glottis held open by the endotracheal tube (17). During each experiment the heart rate was kept constant by pacing from the atrium. Small amounts ofatropine (0.2-1 mg i.v.) were administered as needed to prevent atrio-ventricular block in the animals that received ouabain.
In six dogs, the effect of dobutamine (10 ,Ag/kg per min i.v.), ouabain (0.5 mg i.v.), ouabain (0.5 mg i.v.) after propanolol (2 mg/kg i.v.), and ouabain (0.5 mg i.v.) after phentolamine (5 mg i.v.) were assessed on different days. During each study, data were recorded during a steady-state, nonintervention period to obtain baseline values. The PEs-VEs and dP/dtmaX VED relations were then generated by sudden occlusion ofthe cavae. This caused a progressive fall in LV end-systolic pressure, volume, and dP/dtma. over a 12-s recording period. Immediately after the recording period, the caval occlusion was released. After all parameters had returned to their baseline level, the caval occlusion was repeated. Then dobutamine was infused or ouabain given. The animal was allowed to equilibriate for 5 min (dobutamine infusion) or 10 min (ouabain), and then the measurements were repeated.
In four animals pretreated with atropine (2 mg i.v.), the effects of incremental infusions of dobutamine (0, 2, 4, 6, 8 g/kg per min) were assessed in a similar manner. Finally, in a separate group of six animals, the effects of ouabain (0.25 mg) given every 5 min to produce total doses of 0.25, 0.50, and 0.75 mg were assessed in a similar manner. Higher doses of ouabain could not be used because they produced junctional and ventricular dysrhythmias.
Data analysis. The stored digitized data were analyzed by computer algorithm (1 1, 17 The time constant (T) of the isovolumic fall in LV pressure was determined by fitting the steady-state data from end-ejection to the time that LV pressure had fallen to 10 mmHg above the end-diastolic pressure to the equation: PLV = Poe -,T + PB, using BMDP program PAR (23) , where t is the time from end-ejection, and P0 and PB are constants determined by the data.
Only caval occlusions that produced a fall in LV systolic pressure of at least 30 mmHg, and that produced no extra systoles, were analyzed. The LV end-systolic pressure-volume data during the fall of LV pressure produced by the caval occlusions were fit to: PES = Emaj, ( VESVO), using the linear least squares technique. The LV VED and dP/dtm.. were fit to dP/dtmax = (dE/dtn.) ( VEDVO), where dE/dtm.. is the slope ofthe relation and V0 is the volume intercept. In animal 2, the ultrasonic dimension crystals malfunctioned before administration of ouabain, thus the effect of this intervention on the PES-VES and dP/dtma-VED relations could not be determined in this animal.
Statistical methods. All results were summarized as the mean+SD, and the level of significance was P < 0.05. Dose-response curves were analyzed using a split-plot, repeated-measures analysis of variance. Multiple comparisons were performed by analysis of variance. Single intergroup comparisons were performed using paired t tests or the Wilcoxon signed rank test (24).
Postmortem studies. At the conclusion of the experiments, the animals were sacrificed and the hearts were examined to confirm the proper positioning of the instrumentation.
Results
Typical analog recordings before and after the infusion of dobutamine and ouabain are shown in Fig. 1 . An analog recording after the occlusion of the vena cava is shown in Fig. 2. Effect of dobutamine. The infusion of dobutamine (10 ,ug/kg per min) significantly increased dP/dtmax, while decreasing tmax, end-diastolic and end-systolic LV volumes, LV enddiastolic pressure, and T. Heart rate was kept constant during dobutamine infusion by atrial pacing at 138±24 beats/min.
The LV end-systolic pressure as well as P0 and PB were unchanged (Table I ). Emax increased from 7.24±4.40 to 13.61±5.80 mmHg/ml (P < 0.05) in response to the infusion of 10 ,ug/kg per min of dobutamine, whereas the volume axis intercept of the PEs-VEs relation was unchanged (Table II) .
Dobutamine also shifted the dP/dtm-VED relation to the left, increasing its slope, dE/dtmax from 63.0±20.4 to 177.1±83.6 mmHg/ml per s (P < 0.05) without changing its volume intercept (Table III) . The increase in dE/dtm4 to 282±170% of control was greater than the increase in Ema,, to 184±57% of control (P < 0.05). These effects of dobutamine (10 sg/kg per min) on the dP/dtm.-VED and PES-VES relations are similar to previous observations reported from our laboratory (4, 11).
Similar dose-related effects on Em., dE/dtxax, tm., and T (P < 0.05) were seen with the incremental infusion oflower doses ofdobutamine (Fig. 3) . Of special note is the progressive fall in tmax and T with incremental doses of dobutamine (Fig. 4) .
Effect ofouabain. The administration of0. ( with a higher dP/dtm. (Fig. 4) increase Ema., they have different effects on tm., T, and the dP/dtmax-VED relation. Dobutamine decreases tm., and T and produces a greater increase in dE/dtma. (slope of dP/dtmx-VED relation) than in Ema. In contrast, ouabain does not alter tm,, or T and produces an equivalent increase in dE/dtmax and Emax. The effects of dobutamine and ouabain on peak elastance (Emax) and time from stimulation to occurrence of peak elastance (tm.) mirror their effects on the time-course of intracellular myocardial Ca2" availability assessed using aequorin (13, 16) . Dobutamine increases peak Ca2" availability and Em. and decreases the time to achieve peak Ca2" and ti.. Ouabain increases peak Ca2" and Em, without altering the time to peak Ca2" and tma. These similarities between the time-course of LV elastance and intracellular Ca2" suggest that despite the complex geometry, LV chamber properties reflect the subcellular events underlying contraction (14, 15) .
Both dobutamine and ouabain are positive inotropes that increase Em , thus shifting the P VES relation to the left.
Dobutamine produces no significant change in V0, the volume intercept of the PES-VEs relation, while with ouabain, V0 is decreased somewhat. This decrease in V0 with ouabain is similar to the change in V0 that has been observed in responses to vasoconstriction (4, 11, 21, 25) . When the acute vasoconstrictive effect of ouabain is blunted by pretreatment with phentolamine, no decrease in VO was seen. Both ouabain and dobut- We found that dobutamine and ouabain have different effects on isovolumic relaxation. Because relaxation is an active process, isovolumic relaxation can be considered part of systole (1) . During this period LV pressure declines exponentially (1, 15, (26) (27) (28) quantified using the time constant (T) of the pressure fall. We assessed the rate of pressure fall using an exponential model including a pressure asymptote. It has been shown that T can be substantially altered by changes in loading conditions, most markedly the afterload (28, 29). In addition, T is also influenced by the rate of contractile inactivation (1). Most positive inotropic interventions such as catecholamine administration decrease T, whereas negative inotropic interventions such as ischemia increase T. This has led to the concept that inotropic state is a determinant ofthe rate ofisovolumic relaxation (30, 31 In conclusion, this study shows that although dobutamine and ouabain are both positive inotropes that increase Ema, dobutamine speeds the rate of LV contraction (tQm) and isovolumic relaxation (T), whereas ouabain does not. These effects of ouabain and dobutamine on global parameters of LV chamber performance mirror their influences on intracellular calcium availability. Furthermore, our observations are consistent with the predictions of the time-varying elastance model of the LV and support its usefulness as a conceptual framework to understand and link the events occurring during isovolumic contraction, at end-systole, and during isovolumic relaxation. 
